跳至主要内容
临床试验/CTRI/2025/02/080289
CTRI/2025/02/080289尚未招募4 期

A single blind randomized controlled clinical study on the efficacy of Nimba aragwadhadi kashaya and Asanadi kashaya in the management of Prameha with special reference to Diabetes mellitus type 2

Dr Vishal Patil1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2025年2月20日最近更新:

试验速览

阶段
4 期
状态
尚未招募
发起方
入组人数
40
试验地点
1
主要终点
To know the reduction in the range of

研究概览

简要总结

Diabetes Mellitus is a major and growing health problem worldwide and an important cause of prolonged ill health and early death. Impaired glucose tolerance and impaired fasting glycemia are risk categories for development of cardiovascular diseases. Diabetes Mellitus is a leading cause for renal failure. Hence the focus of the medical community is on the prevention and treatment of the disease.

Drawback of conventional medicine starts from the development of resistance and adverse drug reactions leads lack of responsiveness in the wide range of the patient community. Prameha i.e. Type 2 Diabetes Mellitus is a chronic metabolic disorder. Characterised by increase in the Blood glucose level. Due to the abnormal insulin production and impaired insulin utilisation or both. Which leads to over time serious damage to the heart, blood vessels, eyes, kidney and nerves.

Ayurveda explained Prameha as a set of complex clinical disorders characterised by increased micturition with aetiology involving genetic predisposition as well as improper dietics and sedentary life style. The signs and symptoms described in prameha have much common with diabetes mellites

Hence the current study aims to reduce the signs and symptoms of the disease and avoiding further development of the disease and its other complications by regulating the blood glucose level with the help of the medicine

研究设计

研究类型
Interventional
分配方式
Coin toss, Lottery, toss of dice, shuffling cards etc
盲法
Participant Blinded

入排标准

年龄范围
30.00 Year(s) 至 65.00 Year(s)(—)
性别
All

入选标准

  • 1.Subjects having majority of clinical features of madhumeha like, a) Excessive urination- Bahu Mutrata b) Turbid urination.
  • Avila Mutrata c) Weakness-Dourbalya d) Thirst – Pipasa e) Excessive Hunger – Kshudhadhikyata 2.Age group of 30-65 years are included. 3.Newly detected subjects having Fasting Blood Sugar less than or equal to 180 mg/dL and Post Prandial Blood Sugar less than or equal to 315 mg/dL. 4.Non-complicated Non insulin-dependent-Diabetes mellitus (NIDDM). 5.Subjects other than that of Exclusive criteria.

排除标准

  • 1.Subjects with diabetic complications 2.Subjects with other systemic disorders 3.Subjects of Type 1 Diabetes Mellitus 4.Gestational diabetes 5.Severe chronic disease 6.Neoplasm 7.Other endocrinal disorders.

结局指标

主要结局

To know the reduction in the range of

时间窗: 30 days

1.Fasting Blood Sugar (FBS)

时间窗: 30 days

2.Post Prandial Blood Sugar (PPBS)

时间窗: 30 days

3.Fasting Urine Sugar (FUS)

时间窗: 30 days

4.Post Prandial Urine Sugar (PPUS)

时间窗: 30 days

次要结局

  • To know the reduction in the Classical signs and symptoms of the Prameha.(60 days)

研究者

发起方
Dr Vishal Patil
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

Dr. Vishal Patil

Shri D.G.M Ayurvedic medical College and hospital, PG and PhD research Centre, Dr S V Savadi road, Shivananda Nagar, Gadag 582103

研究点 (1)

Loading locations...

相似试验